Basit öğe kaydını göster

dc.contributor.authorKURAL, AR
dc.contributor.authorKONUKOGLU, D
dc.contributor.authorATAUS, S
dc.contributor.authorSOLOK, V
dc.contributor.authorAKCAY, T
dc.contributor.authorEROZENCI, A
dc.contributor.authorERBAS, M
dc.date.accessioned2021-03-03T09:55:33Z
dc.date.available2021-03-03T09:55:33Z
dc.date.issued1993
dc.identifier.citationAKCAY T., EROZENCI A., ERBAS M., KONUKOGLU D., ATAUS S., KURAL A., SOLOK V., "URINARY-EXCRETION OF GLYCOSAMINOGLYCANS IN PATIENTS WITH SUPERFICIAL BLADDER-TUMORS", CANCER BIOCHEMISTRY BIOPHYSICS, cilt.13, sa.4, ss.279-281, 1993
dc.identifier.issn0305-7232
dc.identifier.othervv_1032021
dc.identifier.otherav_1faea6b3-3578-4259-b61b-82b8e3632501
dc.identifier.urihttp://hdl.handle.net/20.500.12627/26398
dc.description.abstractUrinary glycosaminoglycan/creatinine (GAG/Cr) ratio was determined in 73 patients with superficial bladder tumors and 34 healthy volunteers. While the mean GAG/Cr value in the tumor group was higher than the control group (11.25 +/- 5.36 vs. 10.11 +/- 2.67) this difference was not statistically significant. However, comparing the urinary GAG/Cr ratio of T1, Grade III and recurrent tumors with the control group revealed statistically significant results (p < 0.01, p < 0.001 and p < 0.02 respectively). Therefore, the urinary GAG/Cr ratio determination in the follow-up of these patients may be used as noninvasive procedure and high levels may be signs of higher grade, higher stage disease.
dc.language.isoeng
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyofizik
dc.subjectBiyokimya
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectYaşam Bilimleri
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.subjectSitogenetik
dc.subjectTemel Bilimler
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectBİYOFİZİK
dc.subjectBiyoloji ve Biyokimya
dc.titleURINARY-EXCRETION OF GLYCOSAMINOGLYCANS IN PATIENTS WITH SUPERFICIAL BLADDER-TUMORS
dc.typeMakale
dc.relation.journalCANCER BIOCHEMISTRY BIOPHYSICS
dc.contributor.department, ,
dc.identifier.volume13
dc.identifier.issue4
dc.identifier.startpage279
dc.identifier.endpage281
dc.contributor.firstauthorID8310


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster